4 ms·
The quick estimate is that US per capita GDP is ~$50k and the population is ~320m. So you can immediately upper bound it at half the population or 160m patients
by gwern 11y ago
The quick estimate is that US per capita GDP is ~$50k and the population is ~320m. So you can immediately upper bound it at half the population or 160m patients (two people earn <100k, which pays for <1 person's treatment). This is why health economics tends to use much lower amounts like $50k per QALY. I don't know if the UK's NHS has approved Ibrutinib, but if they have, they must've gotten a big price break from Pharmacyclics because $100k is way above any price they would approve.
- hawkice 11y agoThe NHS seems to have approved it at ~17% discount (but may be towards a higher risk group because it is only available as a first-line medication if you have a chromosomal anomaly -- I am not sure of the relevance of this but it seems it's not the preferred treatment in other cases): http://www.ukmi.nhs.uk/applications/ndo/record_view_open.asp?newDrugID=5810 http://www.ukmi.nhs.uk/applications/ndo/record_view_open.asp... That lists the per-pill price as about 51 gbp or 75 usd instead of 90 usd.